concept

SUBSTANTIA NIGRA

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SUBSTANTIA NIGRA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

766Connections

1Hypotheses

0Analyses

50Outgoing

50Incoming

0Experiments

0Debates

Summary

SUBSTANTIA NIGRA is a concept in neurodegeneration research. Key relationships include: co discussed, associated with, regulates. Associated with PARKINSON, PARKINSON'S, PARKINSON'S DISEASE. Connected to 79 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	SUBSTANTIA NIGRA
Key Genes/Proteins	AIF1, AKT, ALPHA-SYNUCLEIN, AMPK, AMYLOID, APP
Related Diseases	ALZHEIMER'S DISEASE, APOPTOSIS, ATP
Related Pathways	AMPK SIGNALING

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Substantia Nigra Neurons

cell · 821 words

→

Pathway Diagram

graph TD
    SUBSTANTIA_NIGRA["SUBSTANTIA NIGRA"]
    SUBSTANTIA_NIGRA -->|"interacts"| Dopamine["Dopamine"]
    dopaminergic_neurons["dopaminergic neurons"] -->|"expressed in"| SUBSTANTIA_NIGRA
    Dopamine -->|"interacts"| SUBSTANTIA_NIGRA
    lipopolysaccharide["lipopolysaccharide"] -->|"activates"| SUBSTANTIA_NIGRA
    GCASE["GCASE"] -->|"expressed in"| SUBSTANTIA_NIGRA
    NEURON["NEURON"] -->|"expressed in"| SUBSTANTIA_NIGRA
    PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"expressed in"| SUBSTANTIA_NIGRA
    PARKINSON["PARKINSON"] -->|"expressed in"| SUBSTANTIA_NIGRA
    PLIN2["PLIN2"] -->|"expressed in"| SUBSTANTIA_NIGRA
    NEURODEGENERATION["NEURODEGENERATION"] -->|"expressed in"| SUBSTANTIA_NIGRA
    ALPHA_SYNUCLEIN["ALPHA-SYNUCLEIN"] -->|"expressed in"| SUBSTANTIA_NIGRA

Outgoing (162)

Target	Relation	Type	Str
dopamine-producing neurons	expressed_in	cell_type	0.90
L-DOPA	inhibits	drug	0.70
Dopamine	interacts_with	entity	0.70
STROKE	regulates	disease	0.70
Dopamine	regulates	entity	0.70
Dopamine	activates	entity	0.70
DOPAMINERGIC NEURONS	stabilizes	cell_type	0.70
OXIDATIVE STRESS	activates	phenotype	0.65
TH	causes	gene	0.65
UBIQUITIN	transports	protein	0.65
SYNAPTIC PLASTICITY	regulates	phenotype	0.65
GLIOSIS	interacts_with	phenotype	0.65
BASAL GANGLIA	causes	brain_region	0.65
PARKINSON'S DISEASE	treats	disease	0.65
NEURODEGENERATION	activates	disease	0.65
GLIOSIS	inhibits	phenotype	0.65
Parkinson	loss_affects	entity	0.60
TH	regulates	gene	0.60
DOPAMINERGIC	causes	concept	0.50
DOPAMINERGIC NEURONS	causes	concept	0.50
AADC	activates	concept	0.50
PARKINSON'S	expressed_in	concept	0.50
ST3GAL2	expressed_in	concept	0.50
GENE EXPRESSION	expressed_in	concept	0.50
Proteins	associated_with	protein	0.50
Microbiota	inhibits	process	0.50
Gut Microbiota	inhibits	process	0.50
SYNAPTIC PLASTICITY	co_discussed	entity	0.50
TAU	co_discussed	entity	0.50
TET2	associated_with	gene	0.50
AMYLOID	associated_with	protein	0.50
MACROPHAGE	associated_with	cell_type	0.50
SIRT1	associated_with	gene	0.50
OLIGODENDROCYTES	activates	concept	0.50
DOPAMINERGIC	inhibits	concept	0.50
DOPAMINE	inhibits	concept	0.50
DOPAMINERGIC NEURONS	inhibits	concept	0.50
STRIATUM	causes	concept	0.50
CSF	associated_with	phenotype	0.50
LACTATE	associated_with	phenotype	0.50
TDP-43	co_discussed	entity	0.50
DOPAMINERGIC NEURONS	associated_with	concept	0.50
PARKINSON'S	interacts_with	concept	0.50
TNF	co_discussed	entity	0.50
TREM2	co_discussed	entity	0.50
VENTRAL TEGMENTAL AREA	activates	brain_region	0.50
DOPAMINERGIC	associated_with	concept	0.50
HYPOTHALAMUS	associated_with	concept	0.50
DOPAMINERGIC	interacts_with	concept	0.50
SYNUCLEIN	interacts_with	concept	0.50

Incoming (604)

Source	Relation	Type	Str
PARKINSON'S DISEASE	associated_with	disease	1.00
MICROGLIA	associated_with	cell_type	1.00
DOPAMINERGIC NEURONS	associated_with	cell_type	0.95
DOPAMINERGIC NEURONS	causes	cell_type	0.95
Parkinson's Disease	associated_with	disease	0.95
DOPAMINERGIC NEURONS	expressed_in	entity	0.95
METTL3	expressed_in	gene	0.90
Tyrosine Hydroxylase	expressed_in	enzyme	0.90
neurodegeneration	affects	disease	0.90
m6A deficiency	associated_with	process	0.90
Parkinson'S Disease	associated_with	disease	0.90
MN	associated_with	compound	0.90
Parkinson's disease	affects	disease	0.90
LEPTIN	expressed_in	protein	0.90
FE	associated_with	compound	0.90
alpha-synuclein	causes	protein	0.90
IL-6	expressed_in	protein	0.90
PARK2 Deficiency	causes	phenotype	0.88
MCH Neurons	expressed_in	cell_type	0.85
MCH	expressed_in	protein	0.85
SNCA	causes	protein	0.85
Reduced Gangliosides	biomarker_for	biomarker	0.85
PARKIN	associated_with	gene	0.82
neuroinflammation	affects	disease	0.80
REV-ERBα	expressed_in	protein	0.80
TH	expressed_in	gene	0.80
TP53	expressed_in	gene	0.75
TNF	associated_with	gene	0.74
NF-KB	associated_with	protein	0.74
dopaminergic neurons	expressed_in	cell_type	0.70
Dopamine	interacts_with	entity	0.70
AUTOPHAGY	causes	phenotype	0.70
Parkinson's disease	associated_with	disease	0.70
unfolded protein response	active_in	pathway	0.70
TREM2	expressed_in	gene	0.70
lipopolysaccharide	activates	drug	0.70
BDNF	protects_against	gene	0.70
ASC	expressed_in	gene	0.70
TFEB	protects_against	gene	0.70
TFEB	regulates	gene	0.70
IL-1B	associated_with	gene	0.66
MTOR	associated_with	gene	0.66
TREM2	associated_with	gene	0.66
ASTROCYTES	associated_with	cell_type	0.66
AUTOPHAGY	inhibits	process	0.66
PARKINSON'S DISEASE	causes	disease	0.66
ROS	causes	phenotype	0.65
INFLAMMATION	activates	phenotype	0.65
STRIATUM	produces	brain_region	0.65
OXIDATIVE STRESS	causes	phenotype	0.65

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
AAV-Mediated RGS6 Overexpression in Substantia Nigra Parvoce	0.424	neurodegeneration	Does RGS6 upregulation or D2 autorecepto

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning SUBSTANTIA NIGRA in their description or question text

No additional research found